Amalgamated Bank’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,784
Closed -$3K 3109
2025
Q1
$3K Buy
3,784
+1,704
+82% +$2.37K ﹤0.01% 2800
2024
Q4
$4K Hold
2,080
﹤0.01% 2802
2024
Q3
$4K Hold
2,080
﹤0.01% 2841
2024
Q2
$5K Hold
2,080
﹤0.01% 2790
2024
Q1
$3K Sell
2,080
-4,160
-67% -$6.11K ﹤0.01% 2840
2023
Q4
$11K Sell
6,240
-619
-9% -$1.33K ﹤0.01% 2847
2023
Q3
$31K Hold
6,859
﹤0.01% 2461
2023
Q2
$77K Buy
+6,859
New +$73K ﹤0.01% 2151

Other funds holding PROK

Amalgamated Bank's PROK Position: Q2 2025 in Review

Amalgamated Bank sold out of ProKidney (PROK) in Q2 2025, closing a stake of 3,784 shares — an estimated $3K sold.

Amalgamated Bank first reported a position in PROK in Q2 2023 and held it in 8 quarters. The position peaked at $77K in Q2 2023. 56 funds tracked by Wall St. Rank hold PROK as of Q2 2025.

  • Amalgamated Bank reported no remaining ProKidney position as of Q2 2025 after selling out during the quarter.
  • Amalgamated Bank sold 3,784 ProKidney shares in Q2 2025, an estimated $3K.
  • Amalgamated Bank first reported a position in ProKidney in Q2 2023 and held it in 8 quarters.
  • Amalgamated Bank's ProKidney position peaked at $77K in Q2 2023.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.